{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T05:06:46Z","timestamp":1780376806579,"version":"3.54.1"},"publisher-location":"New York, NY","reference-count":44,"publisher":"Springer US","isbn-type":[{"value":"9781071612088","type":"print"},{"value":"9781071612095","type":"electronic"}],"license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021]]},"DOI":"10.1007\/978-1-0716-1209-5_15","type":"book-chapter","created":{"date-parts":[[2021,3,23]],"date-time":"2021-03-23T18:06:40Z","timestamp":1616522800000},"page":"263-277","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["From Homology Modeling to the Hit Identification and Drug Repurposing: A Structure-Based Approach in the Discovery of Novel Potential Anti-Obesity Compounds"],"prefix":"10.1007","author":[{"given":"Giosu\u00e8","family":"Costa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Artese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Ortuso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Alcaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,24]]},"reference":[{"key":"15_CR1","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/nrd3681","volume":"11","author":"JW Scannell","year":"2012","unstructured":"Scannell JW, Blanckley A, Boldon H, Warrington B (2012) Diagnosing the decline in pharmaceutical R&D efficiency. Nat Rev Drug Discov 11:191\u2013200. https:\/\/doi.org\/10.1038\/nrd3681","journal-title":"Nat Rev Drug Discov"},{"key":"15_CR2","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/nrd4051","volume":"12","author":"RM Plenge","year":"2013","unstructured":"Plenge RM, Scolnick EM, Altshuler D (2013) Validating therapeutic targets through human genetics. Nat Rev Drug Discov 12:581\u2013594. https:\/\/doi.org\/10.1038\/nrd4051","journal-title":"Nat Rev Drug Discov"},{"key":"15_CR3","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/nrd1384","volume":"3","author":"B Booth","year":"2004","unstructured":"Booth B, Zemmel R (2004) Prospects for productivity. Nat Rev Drug Discov 3:451\u2013456. https:\/\/doi.org\/10.1038\/nrd1384","journal-title":"Nat Rev Drug Discov"},{"key":"15_CR4","doi-asserted-by":"publisher","first-page":"576","DOI":"10.18632\/oncoscience.173","volume":"2","author":"S Kato","year":"2015","unstructured":"Kato S, Moulder SL, Ueno NT, Wheler JJ, Meric-Bernstam F, Kurzrock R, Janku F (2015) Challenges and perspective of drug repurposing strategies in early phase clinical trials. Onco Targets Ther 2:576\u2013580. https:\/\/doi.org\/10.18632\/oncoscience.173","journal-title":"Onco Targets Ther"},{"key":"15_CR5","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1093\/bib\/bbr021","volume":"12","author":"D Sardana","year":"2011","unstructured":"Sardana D, Zhu C, Zhang M, Gudivada RC, Yang L, Jegga AG (2011) Drug repositioning for orphan diseases. Brief Bioinform 12:346\u2013356. https:\/\/doi.org\/10.1093\/bib\/bbr021","journal-title":"Brief Bioinform"},{"key":"15_CR6","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/nrd1468","volume":"3","author":"TT Ashburn","year":"2004","unstructured":"Ashburn TT, Thor KB (2004) Drug repositioning: identifying and developing new uses for existing drugs. Nat Rev Drug Discov 3:673\u2013683. https:\/\/doi.org\/10.1038\/nrd1468","journal-title":"Nat Rev Drug Discov"},{"key":"15_CR7","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.drudis.2015.09.007","volume":"21","author":"S Mignani","year":"2016","unstructured":"Mignani S, Huber S, Tom\u00e1s H, Rodrigues J, Majoral J-P (2016) Why and how have drug discovery strategies in pharma changed? What are the new mindsets? Drug Discov Today 21:239\u2013249. https:\/\/doi.org\/10.1016\/j.drudis.2015.09.007","journal-title":"Drug Discov Today"},{"key":"15_CR8","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.drudis.2013.11.005","volume":"19","author":"G Jin","year":"2014","unstructured":"Jin G, Wong STC (2014) Toward better drug repositioning: prioritizing and integrating existing methods into efficient pipelines. Drug Discov Today 19:637\u2013644. https:\/\/doi.org\/10.1016\/j.drudis.2013.11.005","journal-title":"Drug Discov Today"},{"key":"15_CR9","doi-asserted-by":"publisher","first-page":"654","DOI":"10.7150\/ijbs.9224","volume":"10","author":"JS Shim","year":"2014","unstructured":"Shim JS, Liu JO (2014) Recent advances in drug repositioning for the discovery of new anticancer drugs. Int J Biol Sci 10:654\u2013663. https:\/\/doi.org\/10.7150\/ijbs.9224","journal-title":"Int J Biol Sci"},{"key":"15_CR10","first-page":"470","volume":"6","author":"CM Krejsa","year":"2003","unstructured":"Krejsa CM, Horvath D, Rogalski SL, Penzotti JL, Mao B, Barbosa F, Migeon JC (2003) Predicting ADME properties and side effects: the BioPrint approach. Curr Opin Drug Discov Devel 6:470\u2013480","journal-title":"Curr Opin Drug Discov Devel"},{"key":"15_CR11","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.tube.2009.07.002","volume":"89","author":"KEA Lougheed","year":"2009","unstructured":"Lougheed KEA, Taylor DL, Osborne SA, Bryans JS, Buxton RS (2009) New anti-tuberculosis agents amongst known drugs. Tuberculosis 89:364\u2013370. https:\/\/doi.org\/10.1016\/j.tube.2009.07.002","journal-title":"Tuberculosis"},{"key":"15_CR12","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1038\/nrd1900","volume":"4","author":"KA O\u2019Connor","year":"2005","unstructured":"O\u2019Connor KA, Roth BL (2005) Finding new tricks for old drugs: an efficient route for public-sector drug discovery. Nat Rev Drug Discov 4:1005\u20131014. https:\/\/doi.org\/10.1038\/nrd1900","journal-title":"Nat Rev Drug Discov"},{"key":"15_CR13","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.2174\/138620709789824682","volume":"12","author":"B Villoutreix","year":"2009","unstructured":"Villoutreix B, Eudes R, Miteva M (2009) Structure-based virtual ligand screening: recent success stories. Comb Chem High Throughput Screen 12:1000\u20131016. https:\/\/doi.org\/10.2174\/138620709789824682","journal-title":"Comb Chem High Throughput Screen"},{"key":"15_CR14","doi-asserted-by":"publisher","unstructured":"F. Sousa S, M.F.S.A. Cerqueira N, A. Fernandes P, Joao Ramos M (2010) Virtual Screening in Drug Design and Development. Combinatorial Chemistry & High Throughput Screening 13:442\u2013453. https:\/\/doi.org\/10.2174\/138620710791293001","DOI":"10.2174\/138620710791293001"},{"key":"15_CR15","doi-asserted-by":"publisher","first-page":"59","DOI":"10.12793\/tcp.2019.27.2.59","volume":"27","author":"K Park","year":"2019","unstructured":"Park K (2019) A review of computational drug repurposing. Translational and Clinical Pharmacology 27:59\u201363. https:\/\/doi.org\/10.12793\/tcp.2019.27.2.59","journal-title":"Translational and Clinical Pharmacology"},{"key":"15_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2019.111565","volume":"181","author":"G Costa","year":"2019","unstructured":"Costa G, Carta F, Ambrosio FA, Artese A, Ortuso F, Moraca F, Rocca R, Romeo I, Lupia A, Maruca A, Bagetta D, Catalano R, Vullo D, Alcaro S, Supuran CT (2019) A computer-assisted discovery of novel potential anti-obesity compounds as selective carbonic anhydrase VA inhibitors. Eur J Med Chem 181:111565. https:\/\/doi.org\/10.1016\/j.ejmech.2019.111565","journal-title":"Eur J Med Chem"},{"key":"15_CR17","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.1152\/jappl.1987.63.5.2134","volume":"63","author":"SJ Dodgson","year":"1987","unstructured":"Dodgson SJ (1987) Inhibition of mitochondrial carbonic anhydrase and ureagenesis: a discrepancy examined. J Appl Physiol 63:2134\u20132141. https:\/\/doi.org\/10.1152\/jappl.1987.63.5.2134","journal-title":"J Appl Physiol"},{"key":"15_CR18","doi-asserted-by":"publisher","first-page":"E791","DOI":"10.1152\/ajpendo.1989.257.6.e791","volume":"257","author":"SJ Dodgson","year":"1989","unstructured":"Dodgson SJ, Cherian K (1989) Mitochondrial carbonic anhydrase is involved in rat renal glucose synthesis. American Journal of Physiology-Endocrinology and Metabolism 257:E791\u2013E796. https:\/\/doi.org\/10.1152\/ajpendo.1989.257.6.e791","journal-title":"American Journal of Physiology-Endocrinology and Metabolism"},{"key":"15_CR19","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1042\/bj3100197","volume":"310","author":"CJ Lynch","year":"1995","unstructured":"Lynch CJ, Fox H, Hazen SA, Stanley BA, Dodgson S, Lanoue KF (1995) Role of hepatic carbonic anhydrase in de novo lipogenesis. Biochem J 310:197\u2013202. https:\/\/doi.org\/10.1042\/bj3100197","journal-title":"Biochem J"},{"key":"15_CR20","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1016\/j.bmc.2012.06.053","volume":"21","author":"RL Arechederra","year":"2013","unstructured":"Arechederra RL, Waheed A, Sly WS, Supuran CT, Minteer SD (2013) Effect of sulfonamides as carbonic anhydrase VA and VB inhibitors on mitochondrial metabolic energy conversion. Bioorg Med Chem 21:1544\u20131548. https:\/\/doi.org\/10.1016\/j.bmc.2012.06.053","journal-title":"Bioorg Med Chem"},{"key":"15_CR21","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1517\/13543776.16.12.1627","volume":"16","author":"A Scozzafava","year":"2006","unstructured":"Scozzafava A, Mastrolorenzo A, Supuran CT (2006) Carbonic anhydrase inhibitors and activators and their use in therapy. Expert Opin Ther Pat 16:1627\u20131664. https:\/\/doi.org\/10.1517\/13543776.16.12.1627","journal-title":"Expert Opin Ther Pat"},{"key":"15_CR22","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/s0960-894x(03)00029-5","volume":"13","author":"A Casini","year":"2003","unstructured":"Casini A, Antel J, Abbate F, Scozzafava A, David S, Waldeck H, Sch\u00e4fer S, Supuran CT (2003) Carbonic anhydrase inhibitors: SAR and X-ray crystallographic study for the interaction of sugar sulfamates\/sulfamides with isozymes I, II and IV. Bioorg Med Chem Lett 13:841\u2013845. https:\/\/doi.org\/10.1016\/s0960-894x(03)00029-5","journal-title":"Bioorg Med Chem Lett"},{"key":"15_CR23","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1016\/j.bmcl.2005.03.032","volume":"15","author":"GD Simone","year":"2005","unstructured":"Simone GD, Fiore AD, Menchise V, Pedone C, Antel J, Casini A, Scozzafava A, Wurl M, Supuran CT (2005) Carbonic anhydrase inhibitors. Zonisamide is an effective inhibitor of the cytosolic isozyme II and mitochondrial isozyme V: solution and X-ray crystallographic studies. Bioorg Med Chem Lett 15:2315\u20132320. https:\/\/doi.org\/10.1016\/j.bmcl.2005.03.032","journal-title":"Bioorg Med Chem Lett"},{"key":"15_CR24","doi-asserted-by":"publisher","first-page":"D198","DOI":"10.1093\/nar\/gkl999","volume":"35","author":"T Liu","year":"2007","unstructured":"Liu T, Lin Y, Wen X, Jorissen RN, Gilson MK (2007) BindingDB: a web-accessible database of experimentally determined protein-ligand binding affinities. Nucleic Acids Res 35:D198\u2013D201. https:\/\/doi.org\/10.1093\/nar\/gkl999","journal-title":"Nucleic Acids Res"},{"key":"15_CR25","doi-asserted-by":"publisher","first-page":"6582","DOI":"10.1021\/jm300687e","volume":"55","author":"MM Mysinger","year":"2012","unstructured":"Mysinger MM, Carchia M, Irwin JJ, Shoichet BK (2012) Directory of useful decoys, enhanced (DUD-E): better ligands and decoys for better benchmarking. J Med Chem 55:6582\u20136594. https:\/\/doi.org\/10.1021\/jm300687e","journal-title":"J Med Chem"},{"key":"15_CR26","doi-asserted-by":"publisher","first-page":"11225","DOI":"10.1021\/ja9621760","volume":"118","author":"WL Jorgensen","year":"1996","unstructured":"Jorgensen WL, Maxwell DS, Tirado-Rives J (1996) Development and testing of the OPLS all-atom force field on conformational energetics and properties of organic liquids. J Am Chem Soc 118:11225\u201311236. https:\/\/doi.org\/10.1021\/ja9621760","journal-title":"J Am Chem Soc"},{"key":"15_CR27","doi-asserted-by":"crossref","unstructured":"Schr\u00f6dinger Release 2017-4: MacroModel, Schr\u00f6dinger, LLC, New York, 2017","DOI":"10.2307\/j.ctvcm4h07.62"},{"key":"15_CR28","doi-asserted-by":"publisher","first-page":"6127","DOI":"10.1021\/ja00172a038","volume":"112","author":"WC Still","year":"1990","unstructured":"Still WC, Tempczyk A, Hawley RC, Hendrickson T (1990) Semianalytical treatment of solvation for molecular mechanics and dynamics. J Am Chem Soc 112:6127\u20136129. https:\/\/doi.org\/10.1021\/ja00172a038","journal-title":"J Am Chem Soc"},{"key":"15_CR29","unstructured":"http:\/\/zinc.docking.org\/"},{"key":"15_CR30","unstructured":"http:\/\/foodb.ca\/"},{"key":"15_CR31","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/s0169-409x(00)00129-0","volume":"46","author":"CA Lipinski","year":"2001","unstructured":"Lipinski CA, Lombardo F, Dominy BW, Feeney PJ (2001) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 46:3\u201326. https:\/\/doi.org\/10.1016\/s0169-409x(00)00129-0","journal-title":"Adv Drug Deliv Rev"},{"key":"15_CR32","doi-asserted-by":"publisher","first-page":"D1074","DOI":"10.1093\/nar\/gkx1037","volume":"46","author":"DS Wishart","year":"2017","unstructured":"Wishart DS, Feunang YD, Guo AC, Lo EJ, Marcu A, Grant JR, Sajed T, Johnson D, Li C, Sayeeda Z, Assempour N, Iynkkaran I, Liu Y, Maciejewski A, Gale N, Wilson A, Chin L, Cummings R, Le D, Pon A, Knox C, Wilson M (2017) DrugBank 5.0: a major update to the DrugBank database for 2018. Nucleic Acids Research 46:D1074\u2013D1082. https:\/\/doi.org\/10.1093\/nar\/gkx1037","journal-title":"Nucleic Acids Research"},{"key":"15_CR33","doi-asserted-by":"crossref","unstructured":"Schr\u00f6dinger Release 2017-4: LigPrep, Schr\u00f6dinger, LLC, New York, 2017","DOI":"10.2307\/j.ctvcm4h07.62"},{"key":"15_CR34","doi-asserted-by":"publisher","first-page":"14726","DOI":"10.1021\/ja3068098","volume":"134","author":"SZ Fisher","year":"2012","unstructured":"Fisher SZ, Aggarwal M, Kovalevsky AY, Silverman DN, McKenna R (2012) Neutron diffraction of acetazolamide-bound human carbonic anhydrase II reveals atomic details of drug binding. J Am Chem Soc 134:14726\u201314729. https:\/\/doi.org\/10.1021\/ja3068098","journal-title":"J Am Chem Soc"},{"key":"15_CR35","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/nar\/28.1.235","volume":"28","author":"HM Berman","year":"2000","unstructured":"Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE (2000) The Protein Data Bank. Nucleic Acids Res 28:235\u2013242. https:\/\/doi.org\/10.1093\/nar\/28.1.235","journal-title":"Nucleic Acids Res"},{"key":"15_CR36","doi-asserted-by":"publisher","first-page":"10949","DOI":"10.1073\/pnas.92.24.10949","volume":"92","author":"PA Boriack-Sjodin","year":"1995","unstructured":"Boriack-Sjodin PA, Heck RW, Laipis PJ, Silverman DN, Christianson DW (1995) Structure determination of murine mitochondrial carbonic anhydrase V at 2.45-a resolution: implications for catalytic proton transfer and inhibitor design. Proc Natl Acad Sci 92:10949\u201310953. https:\/\/doi.org\/10.1073\/pnas.92.24.10949","journal-title":"Proc Natl Acad Sci"},{"key":"15_CR37","doi-asserted-by":"publisher","unstructured":"(2016) UniProt: the universal protein knowledgebase. Nucleic Acids Res 45:D158\u2013D169. https:\/\/doi.org\/10.1093\/nar\/gkw1099","DOI":"10.1093\/nar\/gkw1099"},{"key":"15_CR38","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1002\/prot.10613","volume":"55","author":"MP Jacobson","year":"2004","unstructured":"Jacobson MP, Pincus DL, Rapp CS, Day TJF, Honig B, Shaw DE, Friesner RA (2004) A hierarchical approach to all-atom protein loop prediction. Proteins: Structure, Function, and Bioinformatics 55:351\u2013367. https:\/\/doi.org\/10.1002\/prot.10613","journal-title":"Proteins: Structure, Function, and Bioinformatics"},{"key":"15_CR39","doi-asserted-by":"crossref","unstructured":"Bowers KJ, Chow DE, Xu H, Dror RO, Eastwood MP, Gregersen BA, Klepeis JL, Kolossvary I, Moraes MA, Sacerdoti FD, Salmon JK, Shan Y, Shaw DE (2006) Scalable algorithms for molecular dynamics simulations on commodity clusters. In: ACM\/IEEE SC 2006 conference (SC\u201906). IEEE","DOI":"10.1109\/SC.2006.54"},{"key":"15_CR40","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1063\/1.445869","volume":"79","author":"WL Jorgensen","year":"1983","unstructured":"Jorgensen WL, Chandrasekhar J, Madura JD, Impey RW, Klein ML (1983) Comparison of simple potential functions for simulating liquid water. J Chem Phys 79:926\u2013935. https:\/\/doi.org\/10.1063\/1.445869","journal-title":"J Chem Phys"},{"key":"15_CR41","doi-asserted-by":"publisher","first-page":"6177","DOI":"10.1021\/jm051256o","volume":"49","author":"RA Friesner","year":"2006","unstructured":"Friesner RA, Murphy RB, Repasky MP, Frye LL, Greenwood JR, Halgren TA, Sanschagrin PC, Mainz DT (2006) Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein\u2212ligand complexes. J Med Chem 49:6177\u20136196. https:\/\/doi.org\/10.1021\/jm051256o","journal-title":"J Med Chem"},{"key":"15_CR42","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3310\/hta13suppl1\/06","volume":"13","author":"S Walker","year":"2009","unstructured":"Walker S, Palmer S, Erhorn S, Brent S, Dyker A, Ferrie L, Horsley W, Macfarlane K, White S, Thomas S (2009) Fludarabine phosphate for the first-line treatment of chronic lymphocytic leukaemia. Health Technol Assess 13:35\u201340. https:\/\/doi.org\/10.3310\/hta13suppl1\/06","journal-title":"Health Technol Assess"},{"key":"15_CR43","unstructured":"https:\/\/ncit.nci.nih.gov\/ncitbrowser\/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=NCI_Thesaurus&code=C95124"},{"key":"15_CR44","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1684\/epd.2017.0950","volume":"20","author":"P Striano","year":"2018","unstructured":"Striano P, McMurray R, Santamarina E, Falip M (2018) Rufinamide for the treatment of Lennox-Gastaut syndrome: evidence from clinical trials and clinical practice. Epileptic Disord 20:13\u201329. https:\/\/doi.org\/10.1684\/epd.2017.0950","journal-title":"Epileptic Disord"}],"container-title":["Methods in Molecular Biology","Protein-Ligand Interactions and Drug Design"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-1209-5_15","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,23]],"date-time":"2021-03-23T18:08:50Z","timestamp":1616522930000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-0716-1209-5_15"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"ISBN":["9781071612088","9781071612095"],"references-count":44,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-1209-5_15","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021]]},"assertion":[{"value":"24 March 2021","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}